publication . Article . 2020


E. L. Nasonov;
Open Access
  • Published: 01 Apr 2020 Journal: Rheumatology Science and Practice, volume 58, pages 123-132 (issn: 1995-4484, eissn: 1995-4492, Copyright policy)
  • Publisher: Mediar Press
In December 2019, an outbreak of a novel infection under the working name 2019-nCoV was registered in Wuhan (the Hubei Province located in China’s central region), which has quickly spread throughout almost the entire world and become pandemic. The World Health Organization (WHO) proposed a new name coronavirus disease (COVID-19) for this disease, whereas the International Committee on Virus Taxonomy renamed 2019-nCov as SARS-Cov-2 (Severe Acute Respiratory Syndrome Coronavirus-2). The development of the COVID-19 pandemic is not only of great social importance, but also draws the attention of a medical community to the fundamentally new clinical and fundamental ...
Persistent Identifiers
free text keywords: covid-19, sars-cov-2, acute respiratory distress syndrome, immune-mediated oinflammatory rheumatic diseases, Coronavirus disease 2019 (COVID-19), Virology, Medicine, business.industry, business, lcsh:Diseases of the musculoskeletal system, lcsh:RC925-935
Any information missing or wrong?Report an Issue